Clinical Trial Update: The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing the dose response of niacin extended-release and lovastatin on peak walking time in patients with intermittent claudication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Vascular Disease

Drugs mentioned

• Lovastatin (Lovastatin)
• Niacin ER (niacin extended-release)

Snippet

Sponsor: Kos Pharmaceuticals | Conditions: Intermittent Claudication, Peripheral Vascular Disease | Phase 3 | Status: COMPLETED